 |
|
|
| |
Incidence and Prevalence of Extrahepatic Manifestations of HCV
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Hashem El-Serag1,2; Israel C. Christie1,2; Amy Puenpatom3; Diana Castillo1; Fasiha Kanwal1,2; Jennifer R. Kramer1,2
1Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA; 2Department of Medicine, Baylor College of Medicine, Houston, TX, USA; 3Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
